By year-end, the United Arab Emirates (UAE) can expect to have a new manufacturing plant producing drugs for the country as a Saudi drugmaker completes the…

It was just 6 months ago that vaccines specialist CSL closed on its $275 million buyout of Novartis' influenza vaccines operations, getting three…

Recipharm has been continent-hopping to do a series of deals that expand both its geographic reach and its capabilities. Last fall, it struck a deal to buy an…

GlaxoSmithKline is upping its presence in India again, this week saying it'll spend INR500 million ($73 million) on a plant upgrade in Nashik to expand…

Capsulemaker Qualicaps is adding another country, and another continent, to its manufacturing network. It has secured a spot in Brazil with the acquisition of…

Catalent's plant in Beinheim, France, offline for four months because of suspected sabotage to products, is expected to be fully up and running next…

Some drugmakers are expanding production in Africa to take advantage of a growing number of countries where rising incomes and national healthcare can pay for…

Two years after starting construction on a 91,500-square-foot multipurpose facility in Schuetzenstrasse, Germany, CDMO Vetter has finished work there and…

Partnering